Actively Recruiting
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Led by University of Utah · Updated on 2025-06-13
300
Participants Needed
1
Research Sites
159 weeks
Total Duration
On this page
Sponsors
U
University of Utah
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
CONDITIONS
Official Title
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- LMS patient with an actionable germline pathogenic variant detected in research
- Currently living
- No prior germline testing for this pathogenic variant
- Able to speak and read English
- Mentally competent
- Age 18 or older
- Relative of LMS patient with 25-50% chance of inheriting the pathogenic variant
- No prior germline testing for this pathogenic variant
- Able to speak and read English
- Mentally competent
- Age 18 or older
You will not qualify if you...
- Under 18 years old
- Unable to read or write
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Huntsman Cancer Institute at the University of Utah
Salt Lake City, Utah, United States, 84112
Actively Recruiting
Research Team
G
Gregg Wood
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here